CELGENE CORP /DE/ Insider Trading $CRSP CRISPR Therapeutics AG
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CELGENE CORP /DE/.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CELGENE CORP /DE/. CELGENE CORP /DE/ is 10% Owner in BRISTOL MYERS SQUIBB CO ($BMY) and in CELGENE CORP /DE/ ($CELG) and 10% Owner in CELGENE CORP /DE/ ($CELG) and 10% Owner in CASI Pharmaceuticals, Inc. ($CASI) and 10% Owner in Alliqua BioMedical, Inc. ($ALQA) and in ACCELERON PHARMA INC ($XLRN) and 10% Owner in ACCELERON PHARMA INC ($XLRN) and in SUTRO BIOPHARMA INC ($STRO) and 10% Owner in Abraxis BioScience, Inc. ($ABII) and 10% Owner in AGIOS PHARMACEUTICALS INC ($AGIO) and 10% Owner in CRISPR Therapeutics AG ($CRSP).
CELGENE CORP /DE/ in CRISPR Therapeutics AG
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of CELGENE CORP /DE/: 10% Owner
Holdings: 4,812,221 shares
Current Value: $75,792,481
Latest Transaction: Dec 07 2017
$CRSP Market Capitalization: $605.88M
$CRSP Previous Close: $15.75
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of CELGENE CORP /DE/ in CRISPR Therapeutics AG
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ABII, XLRN, ALQA, AGIO, BMY, CASI, CELG, CRSP, STRO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.47 | 30,485 | 593,543 | 3,722,534 | 3.8 M to 3.7 M (-0.81 %) |
| Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.10 | 87,991 | 1,680,628 | 3,753,019 | 3.8 M to 3.8 M (-2.29 %) |
| Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.04 | 12,666 | 241,161 | 3,841,010 | 3.9 M to 3.8 M (-0.33 %) |
| Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.25 | 4,263 | 82,063 | 3,853,676 | 3.9 M to 3.9 M (-0.11 %) |
| Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.22 | 5,080 | 97,638 | 3,857,939 | 3.9 M to 3.9 M (-0.13 %) |
| Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.75 | 27,990 | 552,803 | 3,863,019 | 3.9 M to 3.9 M (-0.72 %) |
| Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 20.00 | 26,010 | 520,200 | 3,891,009 | 3.9 M to 3.9 M (-0.66 %) |
| Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.76 | 256,000 | 5,058,560 | 3,917,019 | 4.2 M to 3.9 M (-6.13 %) |
| Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.25 | 80,000 | 1,540,000 | 4,173,019 | 4.3 M to 4.2 M (-1.88 %) |
| Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.02 | 158,718 | 3,018,816 | 4,253,019 | 4.4 M to 4.3 M (-3.60 %) |
| Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 18.44 | 51,282 | 945,640 | 4,411,737 | 4.5 M to 4.4 M (-1.15 %) |
| Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 18.39 | 105,000 | 1,930,950 | 4,463,019 | 4.6 M to 4.5 M (-2.30 %) |
| Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 17.67 | 15,000 | 265,050 | 4,568,019 | 4.6 M to 4.6 M (-0.33 %) |
| Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 17.19 | 14,907 | 256,251 | 4,583,019 | 4.6 M to 4.6 M (-0.32 %) |
| Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 17.76 | 65,093 | 1,156,052 | 4,597,926 | 4.7 M to 4.6 M (-1.40 %) |
| Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 17.28 | 10,000 | 172,800 | 4,663,019 | 4.7 M to 4.7 M (-0.21 %) |
| Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 17.08 | 20,000 | 341,600 | 4,673,019 | 4.7 M to 4.7 M (-0.43 %) |
| Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 18.06 | 16,875 | 304,763 | 4,693,019 | 4.7 M to 4.7 M (-0.36 %) |
| Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 18.54 | 23,000 | 426,420 | 4,709,894 | 4.7 M to 4.7 M (-0.49 %) |
| Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 18.89 | 79,327 | 1,498,487 | 4,732,894 | 4.8 M to 4.7 M (-1.65 %) |
| Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.10 | 22,759 | 434,697 | 4,812,221 | 4.8 M to 4.8 M (-0.47 %) |
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Option Exercise | C | 0.00 | 4,034,830 | 0 | 0 | |
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Buy | P | 14.00 | 800,150 | 11,202,100 | 4,834,980 | 4 M to 4.8 M (+19.83 %) |
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Buy | C | 0.00 | 4,034,830 | 0 | 4,034,830 | 0 to 4 M |
Page: 1